Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
IU Amarasena, S Chatterjee… - Cochrane Database …, 2015 - cochranelibrary.com
Background Small cell lung cancer (SCLC) is a very fast growing form of cancer and is
characterised by early metastasis. As a result, chemotherapy is the mainstay of treatment. A …
characterised by early metastasis. As a result, chemotherapy is the mainstay of treatment. A …
Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without …
JL Pujol, JP Daurès - British journal of cancer, 2000 - nature.com
Chemotherapy is the backbone of small-cell lung cancer therapy. However, optimal drug
combinations and schedules remain to be defined and there is hitherto no world-wide …
combinations and schedules remain to be defined and there is hitherto no world-wide …
Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America: Meaningful improvements in survival
PA Jänne, B Freidlin, S Saxman, DH Johnson… - Cancer, 2002 - Wiley Online Library
BACKGROUND To determine the changes in clinical trials and outcomes of patients with
limited‐stage small cell lung carcinoma (SCLC) treated on Phase III randomized trials …
limited‐stage small cell lung carcinoma (SCLC) treated on Phase III randomized trials …
Lung cancer: current concepts and prospects.
JR Jett, DA Cortese, RS Fontana - CA: A Cancer Journal for …, 1983 - europepmc.org
In the United States, lung cancer is now the leading cancer killer among men, and it will
soon be the leader among women. Most lung cancers are attributable to cigarette smoking …
soon be the leader among women. Most lung cancers are attributable to cigarette smoking …
Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.
RJ Klasa, N Murray, AJ Coldman - Journal of clinical oncology, 1991 - ascopubs.org
To determine if chemotherapy dose intensity (DI) influences treatment outcome, 60
published studies in limited-and extensive-stage small-cell carcinoma of the lung (SCCL) …
published studies in limited-and extensive-stage small-cell carcinoma of the lung (SCCL) …
The effect of CNS metastases on the survival of patients with small cell cancer of the lung
GA van Hazel, M Scott, RT Eagan - Cancer, 1983 - Wiley Online Library
The records of 227 patients with small cell lung cancer (SMCLC) treated between January
1974 and July 1978 in a series of randomized trials were reviewed to determine the …
1974 and July 1978 in a series of randomized trials were reviewed to determine the …
Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer.
PA Bunn Jr, FA Greco, L Einhorn - Seminars in Oncology, 1986 - europepmc.org
The discovery that etoposide is one of the most active drugs in small-cell lung cancer
(SCLC) led to its incorporation into a number of first-line combination chemotherapy …
(SCLC) led to its incorporation into a number of first-line combination chemotherapy …
Small cell carcinoma of the lung: An overview
RL Comis, G Martin - Seminars in Oncology Nursing, 1987 - Elsevier
S MALL CELL lung cancer (SCLC) represents about 25% to 30% of all lung cancers,
accounting for approximately 30,000 deaths in 1986.1 Its clinical biology differs from the …
accounting for approximately 30,000 deaths in 1986.1 Its clinical biology differs from the …
Intensive cytosine arabinoside therapy in small cell carcinoma of the lung
JF O'Donnell, LH Maurer, RJ Forcier… - American journal of …, 1984 - journals.lww.com
Abstract CYTOSINE ARABINOSIDE (ARA-C) 100 MG/M 2/D WAS given by continuous
infusion to patients with small cell carcinoma of the lung in two simultaneous studies. In a …
infusion to patients with small cell carcinoma of the lung in two simultaneous studies. In a …
Update in Cancer Chemotherapy, Part IV: Lung Cancer, Part 2
JC Wright - Journal of the National Medical Association, 1985 - ncbi.nlm.nih.gov
An update of cancer chemotherapy in 1985 that deals with the various therapies of lung
cancer is described. At present, the stage of the disease and cell type are the major factors …
cancer is described. At present, the stage of the disease and cell type are the major factors …